A healthy 21-year-old female presented to the ED with symptoms that progressed from depression, headaches, and nausea to word-finding difficulties, psychosis, and seizures. She developed SE and was intubated. A comprehensive evaluation was unremarkable, and she was transferred to our institution on hospital day 11 where an electro-encephalogram (EEG) revealed RSE. The NMDAR antibody was detected in her CSF. A thorough investigation was negative for any tumor. Despite corticosteroids, plasmapheresis, IV Ig in addition to 5 anticonvulsant medications and propofol, continuous EEG showed RSE. Ketosis was achieved after a KD (ratio of fat: Combined carbohydrate and protein of 4:1) was started (day 21). Her continuous EEG showed a significant decrease in her seizures within 2 weeks (day 35). She was weaned off mechanical ventilation and discharged to a long-term care facility on 3 anticonvulsant medications, mycophenolate mofetil, and on a KD.
Most patients with NMDARE develop a multistage illness that progresses to psychosis, memory deficits, RSE, and into a state of unresponsiveness with catatonic features.
[1] Management of NMDARE should initially focus on immunotherapy and the detection and removal of the tumor. [2, 3] Most patients receive corticosteroids, PLEX, or IV Ig as first-line immunotherapy. Additional treatment with second-line cyclophosphamide or rituximab is sometimes needed. Our patient continued to deteriorate despite these therapies. A KD, by reducing the firing of central neurons by opening K ATP channels [4] , is a very effective adjunct to antiepileptics in patients with refractory epilepsy. Side effects of KD [5] are usually mild, predictable, and preventable, and rarely lead to diet discontinuation. Important ones include constipation, acidosis, dyslipidemia, kidney stones, and bone fractures.
To our knowledge, this is the first case report of initiating a KD as an adjunct in RSE from NMDARE.
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Early detection of adult onset Susac's syndrome in a South Indian female
Sir, Since the first description of Susac's Syndrome (SS) in 1979, about 304 cases of SS have been reported, [1] mainly in Western countries. To the best of our knowledge, it is a case of adult onset of SS diagnosed at early stage reported first time from south India and it is the second case reported from India. clinical picture of encephalopathy, branch retinal artery occlusions (BRAOs), and hearing loss in combination with the characteristic imaging features, the patient was diagnosed with SS. She was started on high dose of methylprednisolone (1,000 mg/day) for 5 days, and then tapering dose of oral steroids at the time of discharge. She was relieved from her headache and showed improvement in her vision after 1 month of discharge clinically. She did not return for subsequent follow-up visits. SS is a rare syndrome defined by the clinical triad of encephalopathy, BRAOs, and hearing loss. [2, 3] Women in their 3 rd and 4 th decades of life are predominantly affected with a Male: Female ratio of 1:3. The mean age is 28 years with a range of 9-58 years. [4] Headache is the first symptom and it may occur 6 months before the onset of the other symptoms. [5] Encephalopathy can manifest as headache, confusion, memory loss, behavioral changes, ataxia, and dysarthria. [2, 3, [6] [7] [8] Involvement of the corpus callosum, inparticular, evidence of 'snowball lesions' is considered a characteristic sign of this syndrome. [9] Many lesions in the corpus callosum become cystic within a period of 4 weeks, which is highly suggestive of microinfarcts rather than demyelination, and it can be used to differentiate demyelinating disease. [4] Optic changes include scotoma and visual distortion; however, BRAOs may occur at the periphery and not result in clinical deficits. Hearing loss, usually in the low to mid frequencies, may be associated with roaring tinnitus and vertigo. [3, 7, 8] In general, encephalopathic symptoms and visual disturbances can often be treated and may remit; however, hearing loss is often irreversible. [3] Autoimmune process is the alleged etiology for this disease, [3, 5] but the exact etiology and pathogenesis are still unknown. An immune response triggered by prior infection has been suggested. [6] Although, SS is a self-limiting disease, if not diagnosed and treated early it might lead to permanent hearing and visual loss. Susac et al., recommended the treatment, which includes pulse of methylprednisolone, intravenous immunoglobulin, oral prednisone, and cyclophosphamide. [5] Similar strategy, using high dose methylprednisolone and then tapering dose of oral steroids at the time of discharge helped our case with considerable improvement. In conclusion, early detection of the syndrome is important because it may minimize permanent cognitive, audiologic, and visual sequelae. 
